Pelthos Therapeutics Inc.
PTHS•NYSEAMERICAN•Healthcare•Biotechnology

About Pelthos Therapeutics

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOScott Plesha
Founded2002
Employees11
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNYSEAMERICAN (NYSEAMERICAN)
CurrencyUSD - USD
TypeStock

Contact Information

Websitepelthos.com
Phone877 265 8266
Address
4020 Stirrup Creek Drive, Suite 110 Durham, North Carolina 27703 United States

Corporate Identifiers

CIK0001919246
ISINUS1711262048
EIN86-3335449
SIC2836

Leadership Team & Key Executives

Scott M. Plesha
Chief Executive Officer, President and Director
Francis Knuettel II, M.B.A.
Chief Financial Officer, Secretary and Treasurer
Sai Rangarao M.B.A.
Chief Commercial Officer